in Cohort 2 (2.515.0 mg), patients receiving tirzepatide followed the same dose increments as Cohort 1, but with two further dose increases to the maximum dose of 15.0 mg
A BMI of 35 or higher, coupled with at least one significant obesity-related comorbidity
High doses (12.5-15 mg weekly): Roughly $300-$400/month
doi: 10.3803/EnM.2021.102 Summary Keywords GLP-1 receptor agonists, endocrine, cardiovascular, neurological, cancer Citation Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, Xue H, Liu Y and Zhang Y (2021) GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Try Intermittent Fasting Intermittent fasting (IF) can work brilliantly for some perimenopausal women and backfire spectacularly for others
Coordinate with your healthcare provider to create a skincare routine that avoids conflicting treatments